The Emmes Corporation

Private | Majority Recapitalization | Behrman Capital

Leading contract research organization that partners with public, private foundation, and commercial biopharmaceutical clients to develop new treatment options for diseases and disorders impacting public health

Case

Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to The Emmes Corporation (“Emmes” or the “Company”) on its majority recapitalization with Behrman Capital (“Behrman”). Over several years we assisted the Company in preparing for a transaction. This process began with assessing shareholder objectives and included evaluating strategic alternatives, recommending initiatives to enhance value and preparing for the transaction process. Delancey then executed a tailored process that identified Behrman as the best partner to support Emmes in its next phase of growth. We are honored to have been part of the Emmes story and look forward to the Company’s continued success.

March 2019
The Emmes Corporation
Majority recapitalization with Behrman Capital
Sector: Healthcare
Delancey Street Partners served as the exclusive financial advisor to The Emmes Corporation

Delancey Street Partners is pleased to announce that we served as exclusive financial advisor to The Emmes Corporation (“Emmes” or the “Company”) on its majority recapitalization with Behrman Capital (“Behrman”). Over several years we assisted the Company in preparing for a transaction. This process began with assessing shareholder objectives and included evaluating strategic alternatives, recommending initiatives to enhance value and preparing for the transaction process. Delancey then executed a tailored process that identified Behrman as the best partner to support Emmes in its next phase of growth. We are honored to have been part of the Emmes story and look forward to the Company’s continued success.

About

March 2019
The Emmes Corporation
Majority recapitalization with Behrman Capital
Sector: Healthcare
Delancey Street Partners served as the exclusive financial advisor to The Emmes Corporation

Situation

Emmes is a leading contract research organization that partners with public, private foundation, and commercial biopharmaceutical clients to develop new treatment options for diseases and disorders impacting public health. The Company provides a full suite of clinical research services as well as a number of supporting specialty, analytical, and technology services. In particular, Emmes is the pre-eminent provider of biostatistics-related services such as protocol development, study design, study monitoring, data analysis, data management, and data reporting with expertise across a wide range of therapeutic areas. Emmes has more than 600 highly skilled and experienced employees across the U.S., Canada, and India, and serves clients globally. The Emmes Corporation was founded in 1977 and is headquartered in Rockville, Maryland.

Based in New York City and San Francisco, Behrman Capital was founded in 1991 by Grant G. and Darryl G. Behrman. The firm invests in management buyouts, leveraged buildups and recapitalizations of established growth businesses. The company’s investments are focused in three industries: aerospace and defense, healthcare services, and specialty manufacturing and distribution. The firm has raised in excess of $3.0 billion since inception and is currently investing out of its sixth fund.

Delancey Street Partners is an independent, industry-focused investment bank. We serve CEOs, Entrepreneurs, Shareholders and Boards of Directors of high growth and middle market private and public companies. Our services include strategic advisory, capital raising and independent board advice. We advise on sell-side and buy-side M&A, growth capital financings and recapitalizations. Our focus sectors include Healthcare, Business & Technology Services, Industrial & Industrial Technology, and Infrastructure. We form long-term partnerships with our clients and commit to managing each engagement with senior professionals who bring years of experience and insight.

Result

The transaction was completed March 1, 2019.
The principals of Delancey Street Partners have significant experience serving the Healthcare industry. To learn about our experience in Healthcare, please click here.

For additional information about this transaction, please contact:

Additional

Information

The transaction was completed March 1, 2019.
The principals of Delancey Street Partners have significant experience serving the Healthcare industry. To learn about our experience in Healthcare, please click here.

For additional information about this transaction, please contact:

B. Andrew Schmucker

Managing Partner Phone: (484) 533 – 6313

B. Andrew Schmucker

Click to Email

William J. Filip

Managing Director Phone: (484) 533 – 6312

William J. Filip

Click to Email

We Work With
Great Companies

We want to work with you. Contact us to learn how we can assist in maximizing the value of your business.